Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

Market Cap	103.02B
Revenue (ttm)	82.52B
Net Income (ttm)	15.34B
Shares Out	6.10M
EPS (ttm)	2,514.13
PE Ratio	6.71
Forward PE	n/a
Dividend	800.00 (4.73%)
Ex-Dividend Date	Dec 27, 2024

Volume	4,485
Average Volume	6,688
Open	16,860
Previous Close	16,840
Day's Range	16,670 - 16,920
52-Week Range	15,400 - 23,500
Beta	0.22
RSI	40.61
Earnings Date	Nov 14, 2025

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con...

• Industry: Pharmaceutical Preparations
• Founded: 1945
• Employees: 296
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009300

Financial Performance

In 2024, Sam-A Pharm.'s revenue was 95.58 billion, a decrease of -1.68% compared to the previous year's 97.21 billion. Earnings were 22.08 billion, an increase of 3.30%.